Tg Therapeutics (TGTX) EBT Growth (1y) (2012 - 2026)
Tg Therapeutics (TGTX) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 272.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272.40% |
| Dec 31, 2025 | 72.59% |
| Sep 30, 2025 | 507.05% |
| Jun 30, 2025 | 371.99% |
| Mar 31, 2025 | 151.21% |
| Dec 31, 2024 | 287.72% |
| Sep 30, 2024 | -96.25% |
| Jun 30, 2024 | 113.76% |
| Mar 31, 2024 | 72.78% |
| Dec 31, 2023 | 83.27% |
| Sep 30, 2023 | 378.13% |
| Jun 30, 2023 | 15.33% |
| Mar 31, 2023 | 47.78% |
| Dec 31, 2022 | 12.58% |
| Sep 30, 2022 | 60.30% |
| Jun 30, 2022 | 33.33% |
| Mar 31, 2022 | 18.34% |
| Dec 31, 2021 | -9.17% |
| Sep 30, 2021 | 99.80% |
| Jun 30, 2021 | 99.75% |